SCHEMBL3658862

SCHEMBL3658862

CC(=O)c1ccc2ccc(F)cc2c1

nearest known ligand 0.63

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 2/20 0.63
ALDH1A1 P00352 3/20 0.50
MAPT P10636 2/20 0.50
HPGD P15428 2/20 0.50
KMT2A Q03164 4/20 0.45
MEN1 O00255 2/20 0.45
NPC1 O15118 2/20 0.45
RAB9A P51151 2/20 0.45
CYP1A2 P05177 1/20 0.45
MAOB P27338 5/20 0.44
KDM4E B2RXH2 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
GAA P10253 2/20 0.41
CES2 O00748 2/20 0.41
CES1 P23141 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL405219 0.94 CYP2A6 (0.55) CYP2A6ALDH1A1MAPTHPGDKMT2A
SCHEMBL599006 0.87 CYP2A6 (0.79) CYP2A6ALDH1A1MAPTHPGDKMT2A
SCHEMBL29451111 0.87 CYP2A6 (0.79) CYP2A6ALDH1A1MAPTHPGDKMT2A
SCHEMBL6415513 0.82 BCL2L1 (0.52) CYP2A6ALDH1A1MAPTHPGDKMT2A
SCHEMBL15105728 0.81 CYP2A6 (0.69) CYP2A6ALDH1A1MAPTHPGDKMT2A
SCHEMBL21215857 0.81 CYP2A6 (0.69) CYP2A6ALDH1A1MAPTHPGDKMT2A
SCHEMBL834744 0.80 CYP2A6 (0.68) CYP2A6ALDH1A1MAPTHPGDKMT2A
SCHEMBL23474618 0.80 CYP2A6 (0.45) CYP2A6ALDH1A1MAPTHPGDKMT2A
SCHEMBL3558873 0.79 CYP2A6 (0.68) CYP2A6ALDH1A1MAPTHPGDKMT2A
SCHEMBL31402831 0.78 CYP2A6 (0.66) CYP2A6ALDH1A1MAPTHPGDKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021039616-A1 COMBINATION THERAPY AND BIOMARKER INDICATING EFFICACY THEREOF 大日本住友製薬株式会社 2021-03-04 WO disclosed
EP-2200431-A1 NOVEL COMPOSITIONS AND METHODS FOR CANCER TREATMENT Boston Biomedical, Inc. (US) 2010-06-30 EP disclosed
WO-2009036101-A1 NOVEL COMPOSITIONS AND METHODS FOR CANCER TREATMENT BOSTON BIOMEDICAL, INC. (US) 2009-03-19 WO disclosed